Researchers are multiplying stem cells from umbilical cord blood to treat leukemia
Researcher around Dr. Bernstein from the Fred Hutchinson Cancer Research Center in Seattle published an article in the journal Natural Medicine, in which they described that they were able to multiply stem cells from umbilical cord blood.
This could be a big step in the treatment of leukemia patients in the future. Until now, those affected had had to fight rejection reactions and the lack of donors for bone marrow and stem cell transplants in therapy. And the disadvantage of umbilical cord blood was that it could of course only be collected after pregnancy, during childbirth, and therefore only in small quantities.
It is also spectacular that the blood that the researchers have increased contains quasi-neutral stem cells. So it can be used without hesitation because you don't have to fear any defense reactions like with previous treatments. This type of therapy should also be gentler than conventional methods.
The researchers have already been able to demonstrate that the stem cells that were replicated in the laboratory gained a foothold in human leukemia patients and began to produce new healthy blood cells. Since the number of cells contained in the umbilical cord blood units is lower than in comparable amounts of bone marrow or stem cell donations, the researchers must continue to search for ways of establishing and functioning faster in the organism of those affected. (Thorsten Fischer, non-medical practitioner osteopathy, January 18, 2010)